Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age ≥ 65 Years”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00161954
What this trial is testing

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Not applicableStudy completedNCT04282486
What this trial is testing

Medication Exposure in Older Patients With Constitutional Hemorrhagic Disease

Who this might be right for
Hemophilia
Hospices Civils de Lyon 142
Testing effectiveness (Phase 2)Study completedNCT01949090
What this trial is testing

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Who this might be right for
Influenza
GlaxoSmithKline 363
Post-approval studies (Phase 4)Study completedNCT05154383
What this trial is testing

Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression

Who this might be right for
Vaccine Reaction
Centre Hospitalier Annecy Genevois 60
Testing effectiveness (Phase 2)UnknownNCT02792491
What this trial is testing

Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over

Who this might be right for
Diffuse Large B-cell Lymphoma
Pusan National University Hospital 57
Not applicableStudy completedNCT05155241
What this trial is testing

Controlled Trial Evaluating an Online Intervention in Increasing Seasonal Influenza Vaccination Among Community Dwelling People Aged ≥65 Years

Who this might be right for
Vaccination Refusal
Chinese University of Hong Kong 396
Large-scale testing (Phase 3)Study completedNCT00699192
What this trial is testing

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

Who this might be right for
Hypertension
Novartis Pharmaceuticals 965
Testing effectiveness (Phase 2)Study completedNCT00022152
What this trial is testing

Vinorelbine in Treating Older Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 25
Large-scale testing (Phase 3)Study completedNCT01961947
What this trial is testing

Study of ASP7374, Cell-culture-derived Influenza Vaccine

Who this might be right for
InfluenzaVaccine
UMN Pharma Inc. 900
Not applicableLooking for participantsNCT06961799
What this trial is testing

Validating a Multifactorial Algorithm to Predict Fall Risk in Community Dwelling Older Persons Aged 65 Years or Older

Who this might be right for
Aged 65 Years or OlderCommunity Dwelling Older AdultsFalls Risk+1 more
University Ghent 228
Not applicableStudy completedNCT05602155
What this trial is testing

Partial Weight Bearing Proximal Femoral Nail Due to Intertrochanteric Fracture.

Who this might be right for
Femur Intertrochanteric Fractures
Kahramanmaras Sutcu Imam University 133
Large-scale testing (Phase 3)Study completedNCT00405756
What this trial is testing

Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.

Who this might be right for
Newly Diagnosed Multiple Myeloma
Celgene Corporation 459
Large-scale testing (Phase 3)Study completedNCT04120194
What this trial is testing

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Who this might be right for
Influenza, Human
Novavax 2,654
Large-scale testing (Phase 3)Study completedNCT00219167
What this trial is testing

A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure

Who this might be right for
Hypertension
Novartis 355
Post-approval studies (Phase 4)Study completedNCT05648357
What this trial is testing

Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India

Who this might be right for
Influenza, Human
GlaxoSmithKline 250
Large-scale testing (Phase 3)Study completedNCT01646398
What this trial is testing

Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older

Who this might be right for
Pneumococcal VaccinesPneumococcal Conjugate Vaccine
Pfizer 764
Not applicableLooking for participantsNCT06499623
What this trial is testing

Early Detection of Malnutrition in Oncology Patients and Elderly Patients

Who this might be right for
Malnutrition
Institute of Health Information and Statistics of the Czech Republic 2,000
Not applicableStudy completedNCT06943924
What this trial is testing

A Comparative Study of CCI, EmSFI, and FTRST Scoring Systems

Who this might be right for
One Hundred Patients Aged 65 and Older Who Underwent Emergency General Surgical InterventionsClinical Utility of These Scoring SystemsGastrointestinal Neoplasms+2 more
Dr. Lutfi Kirdar Kartal Training and Research Hospital 100
Early research (Phase 1)Study completedNCT02186626
What this trial is testing

Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age

Who this might be right for
West Nile Virus
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Ended earlyNCT02689726
What this trial is testing

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

Who this might be right for
HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL
Genticel 13
Next Page